drugset / Trial / NCT00576680
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
Phase 1/2
Completed
43 enrolled
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center · collabBrigham and Women's Hospital · collabMassachusetts General Hospital · collabNovartis · collabSchering-Plough · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study will test the safety of RAD001 in combination with temozolomide.
Timeline
- Start
- 2008-05
- Primary completion
- 2019-03-29
- Completion
- 2019-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | Oral |
| Subject | Temozolomide | Small molecule | — | Oral |